Page last updated: 2024-08-26

pyrimidin-2-one beta-ribofuranoside and Cancer of Nasopharynx

pyrimidin-2-one beta-ribofuranoside has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, JY; Ho, WK; Man, OY; To, VS; Tsang, CM; Tsang, RK; Tsao, SW; Wei, WI; Wong, TS1

Other Studies

1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Cancer of Nasopharynx

ArticleYear
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
    Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:3

    Topics: Azacitidine; Carcinoma; Cell Growth Processes; Cell Line, Tumor; Cytidine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Transfection; Up-Regulation

2011